Cargando…
Impact of molecular testing in advanced melanoma on outcomes in a tertiary cancer center and as reported in a publicly available database
BACKGROUND: In patients with advanced melanoma (MM), genomic profiling may guide treatment decisions in the frontline setting and beyond as specific tumor mutations can be treated with targeted therapy (TT). The range of panel sizes used to identify targetable mutations (TM) can range from a few doz...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388178/ https://www.ncbi.nlm.nih.gov/pubmed/34109763 http://dx.doi.org/10.1002/cnr2.1380 |